Astrana Health Q2 revenue up 40% to $486.3M, EPS $0.40; acquires CHS from Centene

Astrana Health, Inc.

2024-Q2 EPS reported $0.71 revenue$890,621,000

Q2 revenue $486.3M (+40% YoY), net income $19.2M (+46%), diluted EPS $0.40 (+43%), adjusted EBITDA $47.9M (+34%).
Six-month revenue $890.6M (+30%), net income $34.0M (+29%), diluted EPS $0.71, adjusted EBITDA $90.2M (+38%).
Entered Arizona via partnership with 45+ PCP group; Hawaii via Elation Health partnership covering ~20K Medicare patients.
Definitive agreement to acquire Collaborative Health Systems from Centene (~2,500 PCPs, 100K+ beneficiaries) expected Q4 2024.
Updated FY2024 revenue guidance $1.75B-$1.85B; reiterated adjusted EBITDA $165M-$185M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.